PROPRANOLOL Drug Patent Profile
✉ Email this page to a colleague
When do Propranolol patents expire, and when can generic versions of Propranolol launch?
Propranolol is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Amta, Anda Repository, Chartwell Rx, Creekwood Pharms, Inwood Labs, Ipca Labs Ltd, Lupin, Micro Labs, Upsher Smith Labs, Zydus Pharms Usa Inc, Baxter Hlthcare Corp, Chartwell Injectable, Fresenius Kabi Usa, Hikma Farmaceutica, Sciegen Pharms, Smith And Nephew, Solopak, Hikma, Pai Holdings, Pai Holdings Pharm, Aiping Pharm Inc, Ani Pharms, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ivax Sub Teva Pharms, Lederle, Mankind Pharma, Mylan, Northstar Hlthcare, Ph Health, Purepac Pharm, Roxane, Sandoz, Schering, Superpharm, Teva, Warner Chilcott, Watson Labs, Watson Labs Teva, and Rising. and is included in one hundred and forty-two NDAs.
The generic ingredient in PROPRANOLOL is hydrochlorothiazide; propranolol hydrochloride. There are two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROPRANOLOL?
- What are the global sales for PROPRANOLOL?
- What is Average Wholesale Price for PROPRANOLOL?
Summary for PROPRANOLOL
| US Patents: | 0 |
| Applicants: | 45 |
| NDAs: | 142 |
| Drug Prices: | Drug price information for PROPRANOLOL |
| Drug Sales Revenues: | Drug sales revenues for PROPRANOLOL |
| DailyMed Link: | PROPRANOLOL at DailyMed |
US Patents and Regulatory Information for PROPRANOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dava Pharms Inc | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 070127-001 | Jul 30, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ivax Sub Teva Pharms | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 072063-001 | Jul 29, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Upsher Smith Labs | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 078311-001 | Mar 6, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
